He is double certified by the American Board of Psychiatry and Neurology in Psychiatry and American Board of Addiction Medicine. His primary research interests are personalized treatment for alcohol and other substance use disorders and psychopharmacology. He received his M.D. from Taipei Medical University in Taiwan, and Ph.D. in molecular psychiatry from the University of London in England. He completed his residency and chief residency in Psychiatry at SUNY Downstate Medical Center in Brooklyn, New York, and research fellowship at Yale University in New Haven, Connecticut. He has authored or co-authored over 40 original research articles, and a few reviews, book chapters on genetics, biomarkers, and neuropharmacology of psychiatric disorders.